5.4 C
New York
Friday, December 3, 2021
- Advertisement -spot_img

TAG

FDA

CTI BioPharma [NASDAQ: CTIC] Reveals FDA Extends Review Period for Pacritinib

CTI BioPharma Corp. disclosed that FDA has informed the company about the decision it has made regarding the NDA for Pacritinib. The company...

QIAGEN [NYSE: QGEN] Announces FDA Approve LIAISON QuantiFERON-TB Gold Plus

QIAGEN N.V. disclosed that it has decided to widen access to latent TB testing in the U.S with its collaboration with DiaSorin. Both...

ObsEva [NASDAQ: OBSV] Announces NDA for Linzagolix Receive FDA Approval

ObsEva SA disclosed that the New Drug Application (NDA) for Linzagolix for the management of heavy menstrual bleeding associated with uterine fibroids in...

Epizyme [NASDAQ: EPZM] Get Fast Track Designation for EZM0414

Epizyme, Inc. disclosed that it has received the Fast-Track designation to EZM0414. EZM0414 is the Company’s novel, first-in-class, oral SETD2 inhibitor, as an...

Why Ocugen [NASDAQ: OCGN] Stock Soaring Today?

Share of Ocugen, Inc. skyrocketed 5% during the trading session of Wednesday. The firm disclosed that it has filed an IND with the...

Johnson & Johnson [NYSE: JNJ] Seeks FDA Approval for COVID-19 Booster Shot

Johnson & Johnson disclosed that it has decided to seek the authorization of the FDA for its COVID-19 booster shot in individuals 18...

RedHill [NASDAQ: RDHL] Announces Trial for COVID-19 Therapy Unable to Meet Endpoint

RedHill Biopharma Ltd. disclosed introductory prime-line data from the 475-victim global Phase 2/3 study with opaganib in hospitalized victims with serious COVID-19 pneumonia....

Ocugen [NASDAQ: OCGN] Selects Manufacturing Partner for COVAXIN

Ocugen, Inc. has disclosed that it has chosen Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVAXIN to make ready for...

Pfizer’s [NYSE: PFE] PREVNAR Got Approval from US FDA

Pfizer Inc. disclosed that US FDA has provided the firm approval for PREVNAR 20 for the avoidance of persistent disease and pneumonia triggered...

Reata [NASDAQ: RETA] is Soaring on Wednesday. Here’s Why

Shares of Reata Pharmaceuticals, Inc. has gained +17.94 at the time of writing on Wednesday. The strong performance of the firm came after...

Latest news

- Advertisement -spot_img